Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial
- Posted on September 28, 2026
- By The Hill
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial
Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
